• The Trump administration has expanded CFIUS powers and outbound investment restrictions targeting China.
  • Bipartisan support underscores the policy's framing as critical to national security.
  • China has countermeasures in place, setting the stage for heightened regulatory tensions.

A New Era of Investment Scrutiny

The White House's February 2025 "America First Investment Policy" memorandum marks a significant escalation in U.S. efforts to monitor and restrict certain cross-border investments with China. The Treasury Department's simultaneous release of a Final Rule implementing outbound investment restrictions provides the Trump administration with what officials describe as "surgical tools" to prevent U.S. capital from advancing China's military capabilities.

"This isn't about closing doors—it's about smart safeguards," said a senior administration official who spoke on condition of anonymity. The measures specifically target transactions involving semiconductors, AI, quantum computing, and other dual-use technologies where Chinese entities might exploit U.S. investments.

Bipartisan Backing Meets Regulatory Muscle

Senators John Cornyn (R-TX) and Catherine Cortez Masto (D-NV) have introduced complementary legislation, signaling rare cross-aisle alignment on China policy. "When it comes to protecting crown jewel technologies, we're speaking with one voice," Cornyn stated during a March 5 committee hearing. The legislative push dovetails with CFIUS's expanded mandate to review smaller transactions that previously flew under the radar.

Market participants are scrambling to adjust. "We're seeing clients preemptively restructure deals that might attract scrutiny," noted a mergers & acquisitions lawyer at a top Wall Street firm. Private equity funds with China exposure have reportedly begun stress-testing portfolios against the new rules.

China's Prepared Response

Beijing isn't caught flat-footed. The 2021 Foreign Investment Security Review Measures created a CFIUS-style review body, while the Unreliable Entities List gives China retaliatory options. Most notably, the CSRC can block Chinese firms from overseas listings—a potential pressure point given hundreds of billions in U.S.-listed Chinese equities.

One wildcard: whether these measures chill legitimate commercial activity. "The compliance burden alone will deter some deals," warned a Hong Kong-based investment banker, noting that middle-market transactions may suffer disproportionate impacts. As both nations weaponize investment flows, companies find themselves navigating an increasingly fraught landscape where every wire transfer carries geopolitical weight.